Trial seeks right dose to shield tiniest babies from harmful inflammation
Disease control
Recruiting now
This study aims to find the safest and most effective dose of a medication called anakinra for very premature babies. It will involve 24 infants born between 24 and 28 weeks of pregnancy. Researchers will test three different doses given by IV and also explore giving it as a shot…
Phase: PHASE2 • Sponsor: Monash Medical Centre • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC